DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Novartis

News

Novartis may Settle US Lawsuit for $1 billion

21.05.2019 - Novartis may be close to a billion-dollar settlement with the US government to resolve a whistleblower lawsuit accusing the Swiss pharmaceuticals giant of bribing doctors to boost...

News

Codexis Signs License Deal with Novartis

17.05.2019 - US protein engineering company Codexis has signed a platform agreement with Novartis, granting the Swiss pharmaceutical producer a non-exclusive license to its proprietary...

News

Takeda Sells Shire Eye Drug Xiidra to Novartis

13.05.2019 - To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...

News

Novartis and Amgen in Migraine Dispute

17.04.2019 - Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...

Topstories

The Need for Innovation in Pharmaceutical Manufacturing

08.04.2019 - The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...

News

Novartis Takes US Biotech IFM Tre

03.04.2019 - Swiss drugmaker Novartis has agreed to buy US biotech IFM Tre in a deal worth nearly $1.6 billion, boosting its portfolio of anti-inflammatory medicines. Novartis will pay $310...

News

Novartis Back in the Spotlight at Cohen Hearing

05.03.2019 - Novartis’ ill-advised attempt two years ago to get an inside look at drugs pricing policies of newly elected US president Donald Trump came back to haunt it last week during the...

News

Novartis Slashes 20% of R&D Programs

19.11.2018 - After completing a portfolio review, Novartis has dropped around 20% of its R&D projects as it narrows its focus to the most cutting-edge medicines. Jay Bradner, president of the...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.